Bridget E. Bunner

Array ( [id] => 7094040 [patent_doc_number] => 20010034438 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-10-25 [patent_title] => 'Novel human membrane protein and polynucleotides encoding the same' [patent_app_type] => new [patent_app_number] => 09/755017 [patent_app_country] => US [patent_app_date] => 2001-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18458 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20010034438.pdf [firstpage_image] =>[orig_patent_app_number] => 09755017 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6209906 [patent_doc_number] => 20020072488 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-13 [patent_title] => 'Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof' [patent_app_type] => new [patent_app_number] => 09/739457 [patent_app_country] => US [patent_app_date] => 2000-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 24441 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20020072488.pdf [firstpage_image] =>[orig_patent_app_number] => 09739457 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5859008 [patent_doc_number] => 20020123091 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-05 [patent_title] => 'Novel inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization' [patent_app_type] => new [patent_app_number] => 09/742201 [patent_app_country] => US [patent_app_date] => 2000-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 55233 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 31 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20020123091.pdf [firstpage_image] =>[orig_patent_app_number] => 09742201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1171924 [patent_doc_number] => 06750026 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-06-15 [patent_title] => 'Screening methods using ligands of the neutropeptide receptor HFGAN72' [patent_app_type] => B2 [patent_app_number] => 09/737379 [patent_app_country] => US [patent_app_date] => 2000-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13940 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/750/06750026.pdf [firstpage_image] =>[orig_patent_app_number] => 09737379 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6048930 [patent_doc_number] => 20020169283 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-14 [patent_title] => 'Clasp-7 transmembrane protein' [patent_app_type] => new [patent_app_number] => 09/736968 [patent_app_country] => US [patent_app_date] => 2000-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 45209 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20020169283.pdf [firstpage_image] =>[orig_patent_app_number] => 09736968 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6627811 [patent_doc_number] => 20020086382 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-04 [patent_title] => 'Clasp-3 transmembrane protein' [patent_app_type] => new [patent_app_number] => 09/737246 [patent_app_country] => US [patent_app_date] => 2000-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 54 [patent_no_of_words] => 48070 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20020086382.pdf [firstpage_image] =>[orig_patent_app_number] => 09737246 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6015017 [patent_doc_number] => 20020102267 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-01 [patent_title] => 'CLASP-5 transmembrane protein' [patent_app_type] => new [patent_app_number] => 09/736960 [patent_app_country] => US [patent_app_date] => 2000-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 61 [patent_figures_cnt] => 61 [patent_no_of_words] => 45244 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20020102267.pdf [firstpage_image] =>[orig_patent_app_number] => 09736960 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6889369 [patent_doc_number] => 20010024824 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-09-27 [patent_title] => 'Stem cells and their use in transplantation' [patent_app_type] => new [patent_app_number] => 09/731255 [patent_app_country] => US [patent_app_date] => 2000-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 18927 [patent_no_of_claims] => 127 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0024/20010024824.pdf [firstpage_image] =>[orig_patent_app_number] => 09731255 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7609947 [patent_doc_number] => 06998239 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-02-14 [patent_title] => 'Method for identifying a modulator of the binding of CCX CKR polypeptide to a chemokine' [patent_app_type] => utility [patent_app_number] => 09/721341 [patent_app_country] => US [patent_app_date] => 2000-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 14 [patent_no_of_words] => 23638 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 193 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/998/06998239.pdf [firstpage_image] =>[orig_patent_app_number] => 09721341 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 158771 [patent_doc_number] => 07674463 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-03-09 [patent_title] => 'Method of inhibiting angiogenesis by administration of a corticotropin releasing factor receptor 2 agonist' [patent_app_type] => utility [patent_app_number] => 09/714692 [patent_app_country] => US [patent_app_date] => 2000-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 28 [patent_no_of_words] => 10736 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/674/07674463.pdf [firstpage_image] =>[orig_patent_app_number] => 09714692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1335189 [patent_doc_number] => 06593108 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-15 [patent_title] => 'Nucleic acid molecule encoding a melanin-concentrating hormone receptor 2 polypeptide' [patent_app_type] => B1 [patent_app_number] => 09/712368 [patent_app_country] => US [patent_app_date] => 2000-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12137 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/593/06593108.pdf [firstpage_image] =>[orig_patent_app_number] => 09712368 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1290852 [patent_doc_number] => 06630348 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-07 [patent_title] => 'Single-chain insulin analog and a polynucleotide sequence encoding the analog' [patent_app_type] => B1 [patent_app_number] => 09/706690 [patent_app_country] => US [patent_app_date] => 2000-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 25 [patent_no_of_words] => 11432 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/630/06630348.pdf [firstpage_image] =>[orig_patent_app_number] => 09706690 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1235911 [patent_doc_number] => 06689753 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-02-10 [patent_title] => ' sheet breaker peptide analogs that inhibit pleated sheet formation in amyloid -peptide' [patent_app_type] => B1 [patent_app_number] => 09/706540 [patent_app_country] => US [patent_app_date] => 2000-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 7608 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/689/06689753.pdf [firstpage_image] =>[orig_patent_app_number] => 09706540 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1291433 [patent_doc_number] => 06630444 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-07 [patent_title] => 'Intestinal function using leptin' [patent_app_type] => B1 [patent_app_number] => 09/693864 [patent_app_country] => US [patent_app_date] => 2000-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 4663 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/630/06630444.pdf [firstpage_image] =>[orig_patent_app_number] => 09693864 [rel_patent_id] =>[rel_patent_doc_number] =>)